---
figid: PMC4724176__nov12502
figtitle: Molecular signaling and the advantages of Warburg
organisms:
- NA
pmcid: PMC4724176
filename: nov12502.jpg
figlink: /pmc/articles/PMC4724176/figure/NOV125F2/
number: F2
caption: Molecular signaling and the advantages of Warburg. The PI3K-AKT-mTOR signaling
  pathway, which is highly deregulated in glioblastoma, directly regulates glycolysis
  and the tricarboxylic acid (TCA) cycle at numerous steps. AKT can promote aerobic
  glycolysis by promoting increases in glucose transport and hexokinase activity (HK2).
  Increased AKT activity can also promote ACL-dependent conversion of citrate to cytosolic
  acetyl-CoA for fatty acid synthesis. Increased glycolysis can promote nucleotide
  synthesis and generate NADH-reducing equivalents for REDOX. Inactive PKM2 can slow
  the rate of glycolysis diverting intermediate metabolites to anabolic pathways.
  mTORC1 stabilization of HIF1a can promote PDK1 activity, diverting pyruvate into
  lactate generation.
papertitle: 'Metabolic reprogramming in glioblastoma: the influence of cancer metabolism
  on epigenetics and unanswered questions.'
reftext: Sameer Agnihotri, et al. Neuro Oncol. 2016 Feb;18(2):160-172.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9340635
figid_alias: PMC4724176__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC4724176__F2
ndex: 3cd36ca5-df09-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4724176__nov12502.html
  '@type': Dataset
  description: Molecular signaling and the advantages of Warburg. The PI3K-AKT-mTOR
    signaling pathway, which is highly deregulated in glioblastoma, directly regulates
    glycolysis and the tricarboxylic acid (TCA) cycle at numerous steps. AKT can promote
    aerobic glycolysis by promoting increases in glucose transport and hexokinase
    activity (HK2). Increased AKT activity can also promote ACL-dependent conversion
    of citrate to cytosolic acetyl-CoA for fatty acid synthesis. Increased glycolysis
    can promote nucleotide synthesis and generate NADH-reducing equivalents for REDOX.
    Inactive PKM2 can slow the rate of glycolysis diverting intermediate metabolites
    to anabolic pathways. mTORC1 stabilization of HIF1a can promote PDK1 activity,
    diverting pyruvate into lactate generation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HGF
  - IL6
  - SOS1
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - EGF
  - FGF1
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - HK2
  - KCNA5
  - KIF2A
  - KLK2
  - HOOK2
  - DECR1
  - PDPK1
  - AKT1
  - AKT2
  - AKT3
  - PAEP
  - PREP
  - PTPN22
  - PKM
  - PKLR
  - ATP8A2
  - TSC2
  - TSC1
  - CCL26
  - RHEB
  - RHEBP1
  - PDP1
  - DLAT
  - DLD
  - PDHA1
  - PDHA2
  - PDHB
  - PDHX
  - PDK1
  - MTOR
  - RPTOR
  - EIF4EBP1
  - HIF1A
  - RPS6KB1
  - ACLY
  - EIF4E
  - EIF4E2
  - EIF4E3
  - Glucose
  - Pentose Phosphate
  - Pyruvate
  - Lactate
  - Cancer
---
